Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mammary gland oncogenes as indicators of pathways important in mammary gland development

Oncogene volume 19, pages 1097–1101 (2000)Cite this article

Abstract

The identification of dominant acting proto-oncogenes in mammary tumors from mice and humans has highlighted a number of signal transduction pathways that have subsequently been shown to have a role in normal mammary growth and differentiation. Here we describe the use of two different transgenic mouse strategies to investigate the function of two of these signalling pathways in the normal growth and differentiation of the mouse mammary gland during pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J. . 1994 Int. J. Cancer 57: 353–361.

  • Basilico C and Moscatelli D. . 1992 Adv. Cancer Res. 59: 115–165.

  • Coleman-Krnacik S and Rosen JM. . 1994 Mol. Endocrinol. 8: 218–229.

  • Dickson C, Fuller-Pace F, Kiefer P, Acland P, MacAllan D and Peters G. . 1991 Annals of the New York Academy of Sciences. 638. Baird A and Klagsbrun M. (eds).. The New York Academy of Sciences: New York pp. 18–26.

    Google Scholar 

  • Dickson C, Smith R, Brookes S and Peters G. . 1984 Cell 37: 529–536.

  • Fantl V, Edwards P, Steel J, Vonderhaar B and Dickson C. . 1999 Devel. Biol. 212: 1–11.

  • Fantl V, Richards M, Smith R, Lammie G, Johnstone G, Allen D, Gregory W, Peters G, Dickson C and Barnes D. . 1990 Eur. J. Cancer 26: 423–429.

  • Fantl V, Stamp G, Andrews A, Rosewell I and Dickson C. . 1995 Genes Dev. 9: 2364–2372.

  • Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G and Smith G. . 1996 Cancer Res. 1775–1785.

  • Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G. . 1994 Cancer Res. 54: 1812–1817.

  • Jackson D, Bresnick J, Rosewell I, Crafton T, Poulson R, Stamp G and Dickson C. . 1997 J. Cell. Science 110: 1261–1268.

  • Johnson D and Williams L. . 1993 Adv. Cancer Res. 60: 1–41.

  • Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A and Peters G. . 1991 Oncogene 6: 439–444.

  • Lammie GA and Peters G. . 1991 Cancer Cells 3: 413–420.

  • MacArthur CA, Shankar DB and Shackleford GM. . 1995 J. Virol. 69: 2501–2507.

  • Mansour SL, Goddard JM and Capecchi MR. . 1993 Development 117: 13–28.

  • Mathieu M, Chatelain E, Ornitz D, Bresnick J, Mason I, Kiefer P and Dickson C. . 1995 J. Biol. Chem. 270: 24197–24203.

  • McKeehan WL, Wang F and Kan M. . 1998 Prog. Nucleic. Acid Res. Mol. Biol. 59: 135–176.

  • Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P and Leder P. . 1990 EMBO J. 9: 907–913.

  • Nusse R. . 1991 Curr. Topics Microbiol. Immunol. 171: 44–65.

  • Ornitz D, Xu J, Colvin J, McEwen D, MacArthur C, Coulier F, Gao G and Goldfarb M. . 1996 J. Biol. Chem. 271: 15292–15297.

  • Peters G. . 1991 Sem. Virol. 2: 319–328.

  • Peters G, Lee A and Dickson C. . 1986 Nature 320: 628–631.

  • Shackleford GM, MacArthur CA, Kwan HC and Varmus HE. . 1993 Proc. Natl. Acad. Sci. USA 90: 740–744.

  • Sherr C. . 1995 TIBS 20: 187–190.

  • Sherr C. . 1996 Science 274: 1672–1677.

  • Sicinski P, Donaher JL, Parker SB, Li TS, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA. . 1995 Cell 82: 621–630.

  • Stamp G, Fantl V, Poulsom R, Jamieson S, Smith R, Peters G and Dickson C. . 1992 Cell Growth & Diff. 3: 929–938.

  • Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T and Varmus HE. . 1988 Cell 55: 619–625.

  • Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. . 1994 Nature 369: 669–671.

  • Weinberg R. . 1995 Cell 81: 323–330.

  • Wilkinson DG, Bhatt S and McMahon AP. . 1989 Development 105: 131–136.

  • Wilkinson DG, Peters G, Dickson C and McMahon AP. . 1988 EMBO J. 7: 691–695.

Download references

Author information

Authors and Affiliations

  1. Imperial Cancer Research fund, Lincoln's Inn Fields, London, WC2A 3PX, UK

    Clive Dickson, Anna Creer & Vera Fantl

Authors
  1. Clive Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Creer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vera Fantl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dickson, C., Creer, A. & Fantl, V. Mammary gland oncogenes as indicators of pathways important in mammary gland development. Oncogene 19, 1097–1101 (2000). https://doi.org/10.1038/sj.onc.1203267

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203267

Keywords

This article is cited by

Search

Advanced search

Quick links